canagliflozin

Johnson & Johnson Invokana PDUFA Preview

Johnson & Johnson Invokana PDUFA Preview

Motley Fool

J&J Seeks EU Nod for Combo Drug

J&J Seeks EU Nod for Combo Drug

Yahoo/Zacks

Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval

Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval

Seeking Alpha

Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval

Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval

Forbes

Can J&J Get Its Diabetes Drug Past the Safety-First FDA?

Can J&J Get Its Diabetes Drug Past the Safety-First FDA?

Motley Fool

Can J&J Get Its Diabetes Drug Past the Safety-First FDA?

Can J&J Get Its Diabetes Drug Past the Safety-First FDA?

Motley Fool

FDA Panel Backs Novel Diabetes Pill From J&J

FDA Panel Backs Novel Diabetes Pill From J&J

Motley Fool

J&J Diabetes Drug Faces Questions at FDA Advisory Panel

J&J Diabetes Drug Faces Questions at FDA Advisory Panel

Motley Fool

Janssen submits NDA to FDA for canagliflozin/metformin

Janssen submits NDA to FDA for canagliflozin/metformin

Yahoo/Fly on the Wall

New Diabetes Drug Can Bolster J&J’s $74 Value

New Diabetes Drug Can Bolster J&J’s $74 Value

Trefis